Myc-associated zinc finger protein: A “double-edged sword” in the malignant process of tumors
New Discovery · 2025
DOI: 10.61958/nday6574 ↗Kurz gefasst
Fachartikel in der Zeitschrift New Discovery, 2025. Verfasst von Yu Feng und 5 weiteren Autor:innen. Die Arbeit nennt 72 Literaturangaben.
Abstract (Originalsprache)
Myc-associated zinc finger protein (MAZ), a cysteine2-Histidine2 (C2H2)-type zinc finger transcription factor, is widely expressed in human tissues and frequently dysregulated in various malignancies, positioning it as a promising target for cancer therapy. MAZ exerts dual regulatory effects on gene transcription by binding to guanine-cytosine-rich (GC-rich) DNA sequences, modulating the transcription of numerous target genes. This review examines the role of MAZ in the progression of hepatocellular carcinoma, breast cancer, renal cancer, pancreatic cancer, prostate cancer, and other malignancies, with a focus on recent advancements in understanding its molecular mechanisms. These insights aim to contribute to the development of improved diagnostic and therapeutic strategies for cancer.
Zitieren
APA
Feng, Y., Xie, T., Huang, Y., Yu, S., Gai, Y., & Ni, Q. (2025). Myc-associated zinc finger protein: A “double-edged sword” in the malignant process of tumors. New Discovery. https://doi.org/10.61958/nday6574
Vancouver
Feng Y, Xie T, Huang Y, Yu S, Gai Y, Ni Q. Myc-associated zinc finger protein: A “double-edged sword” in the malignant process of tumors. New Discovery. 2025. doi:10.61958/nday6574
BibTeX
@article{Feng2025,
author = {Feng, Yu and Xie, Tai-Yu and Huang, Yu and Yu, Song and Gai, Yan-Long and Ni, Qin-Xuan},
title = {Myc-associated zinc finger protein: A “double-edged sword” in the malignant process of tumors},
journal = {New Discovery},
year = {2025},
doi = {10.61958/nday6574}
}
EUVIMED